Thrombolysis is a medical procedure used in cardiology to break up blood clots that have formed in the arteries or veins. It is used to treat a variety of conditions, including stroke, pulmonary embolism, and myocardial infarction. The procedure involves the injection of a thrombolytic agent, such as tissue plasminogen activator (tPA), into the affected area. This agent works to dissolve the clot and restore blood flow. Thrombolysis is a relatively safe procedure, but it does carry some risks, such as bleeding and infection.
The thrombolysis market is a rapidly growing sector of the cardiology industry. It is driven by the increasing prevalence of cardiovascular diseases, the development of new thrombolytic agents, and the growing demand for minimally invasive treatments.
Some of the major players in the thrombolysis market include Boehringer Ingelheim, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. These companies are involved in the development, manufacture, and marketing of thrombolytic agents. Show Less Read more
